Gufic Biosciences Limited

BSE: 509079 NSE: GUFICBIO
Gufic Biosciences Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L24100MH1984PLC033519 Incorporated 23 July 1984 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: GUFICBIO · BSE: 509079 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹944.01 Cr
▲ 15.15% YoY
Computed EBITDA · FY 2026
₹153.99 Cr
▲ 11.33% YoY
Net profit · FY 2026
₹64.21 Cr
▼ 7.8% YoY
Authorised capital
₹85.75 Cr
Registered with MCA
Paid-up capital
₹10.03 Cr
Issued & subscribed
Open charges
₹604.73 Cr
Satisfied ₹201.91 Cr
Company age
42 yrs
Est. 1984
Employees · EPFO
1,362
Latest available

About Gufic Biosciences Limited

Data last updated: 14 July 2026

Gufic Biosciences Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 23 July 1984, the company has been in operation for over 42 years.

Registered with ROC Mumbai under CIN L24100MH1984PLC033519. Listed on BSE: 509079 and NSE: GUFICBIO.

Capital: an authorised share capital of ₹85.75 Cr and a paid-up capital of ₹10.03 Cr. Formerly known as Central Leasing Limited. It is led by directors including Pranav Jayesh Choksi and Anu Sanjiv Aurora.

Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Shop – 37 First Floor Kamala Bhavan Ii S Nityanand Road Andheri East, Mumbai, Maharashtra, India – 400069.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹944.01 Cr, a growth of 15.15% compared to the previous year. The net worth stands at ₹664.99 Cr (up 10.63% YoY). Total assets are valued at ₹1,342.37 Cr (up 14.8% YoY).

The company has a workforce of approximately 1,362 employees as per the latest available data. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Gufic Group. As per MCA filings, the company has open charges of ₹604.73 Cr and satisfied charges of ₹201.91 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gufic.com.

Company Details of Gufic Biosciences Limited
CIN L24100MH1984PLC033519
Registration Number 033519
Incorporation Date 23 July 1984
ROC Mumbai
Listing Status Listed (BSE: 509079, NSE: GUFICBIO)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Jayesh Pannalal Choksi Managing Director Pranav Jayesh Choksi Whole-Time Director Pankaj Jayakumar Gandhi Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    gufic.com
  • Social Media
    Locked
  • Registered Address
    Shop – 37 First Floor Kamala Bhavan Ii S Nityanand Road Andheri East, Mumbai, Maharashtra, India – 400069
  • Industry
    Pharma, Drug Formulation & Development
Company report
Gufic Biosciences Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Gufic Biosciences Limited report

Financials, compliance, directors, charges, ownership and filings for Gufic Biosciences Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Gufic Biosciences Limited

Gufic Biosciences Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24100MH1984PLC033519, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24100MH1984PLC033519 Current
L65990MH1901PLC033519 Previous
L65990MH1984PLC033519 Previous

Associated Brands with Gufic Biosciences Limited

Gufic Biosciences Limited operates one associated brand: Gufic Group. These brands represent Gufic Biosciences Limited's diversified market presence and brand portfolio.

Brand Description Website
Gufic Group
Lyophilized injections and pharmaceutical products are manufactured across therapeutic segments. gufic.com

Business Activity of Gufic Biosciences Limited

Gufic Biosciences Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Gufic Biosciences Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Gufic Biosciences Limited

Gufic Biosciences Limited is audited by M/s. Mittal Agarwal & Company (ICAI peer reviewed, certificate valid till 2028-04-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s. Mittal Agarwal & Company (ICAI peer reviewed, certificate valid till 2028-04-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Gufic Biosciences Limited

Gufic Biosciences Limited is currently managed by 6 directors, with 17 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Pranav Jayesh Choksi
Also directs: Motif Hotels Llp, Gufic Biosciences Limited, Gufic Chem Private Limited and 5 more
Whole-Time Director 25 Jun 2004 22 Years 1 Months Current
Anu Sanjiv Aurora
Also directs: Gufic Biosciences Limited
Director 23 Dec 2019 6 Years 7 Months Current
Pankaj Jayakumar Gandhi
Also directs: Gufic Biosciences Limited, Gufic Chem Private Limited, Gufic Private Limited and 2 more
Whole-Time Director 01 Aug 2013 13 Years 0 Months Current
Jayesh Pannalal Choksi
Also directs: Motif Hotels Llp, Gufic Biosciences Limited, Gufic Chem Private Limited and 5 more
Managing Director 31 Aug 1999 26 Years 11 Months Current
Akshya Kumar Mahapatra
Also directs: Gufic Biosciences Limited, Quantumbio Institute Of Practical Psychophysics (India) Private Limited, Omnicals Pharma Private Limited and 3 more
Director 14 Nov 2024 1 Years 9 Months Current
Kamal Kishore Seth
Also directs: Gufic Biosciences Limited, Ipca Laboratories Limited, Ipca Foundation and 1 more
Director 27 Jun 2024 2 Years 1 Months Current
View all directors

Financials of Gufic Biosciences Limited FY 2026 filings available

Gufic Biosciences Limited reported revenue of ₹944.01 Cr (up 15.15% YoY) for FY 2026.

Revenue · FY 2026
₹944.01 Cr ▲ 15.15%
Profit · FY 2026
₹64.21 Cr ▼ 7.8%
Computed EBITDA · FY 2026
₹153.99 Cr ▲ 11.33%
Revenue₹ Cr · Consolidated05001,000FY 2024: ₹807 Cr807FY 2024FY 2025: ₹820 Cr · +1.6% YoY820+1.6%FY 2025FY 2026: ₹944 Cr · +15.2% YoY944+15.2%FY 2026
Net Profit₹ Cr · Consolidated050100FY 2024: ₹86 Cr86.1FY 2024FY 2025: ₹70 Cr · -19.1% YoY69.6-19.1%FY 2025FY 2026: ₹64 Cr · -7.8% YoY64.2-7.8%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0100200300Q1'25: ₹203 Cr203Q1'25Q2'25: ₹204 Cr · -5% YoY204-5%Q2'25Q3'25: ₹208 Cr · +3% YoY208+3%Q3'25Q4'25: ₹205 Cr · +5.1% YoY205+5.1%Q4'25Q1'26: ₹224 Cr · +10.3% YoY224+10.3%Q1'26Q2'26: ₹237 Cr · +16.1% YoY237+16.1%Q2'26Q3'26: ₹231 Cr · +11.4% YoY231+11.4%Q3'26Q4'26: ₹252 Cr · +22.8% YoY252+22.8%Q4'26
Metrics FY 2026 FY 2025 FY 2024
Revenue from Operations ₹944.01 Cr ₹819.81 Cr ₹806.67 Cr
Other Income ₹2.66 Cr ₹3.63 Cr ₹2.18 Cr
Total Income ₹946.66 Cr ₹823.43 Cr ₹808.84 Cr
Cost of Materials Consumed ₹425.33 Cr ₹344.2 Cr ₹341.32 Cr
Purchases of Stock-in-Trade ₹64.71 Cr ₹55.41 Cr ₹58.06 Cr
Changes in Inventories -₹68.86 Cr -₹24.91 Cr -₹9.49 Cr
Employee Benefit Expense ₹151.68 Cr ₹127.05 Cr ₹109.63 Cr
Finance Costs ₹36.61 Cr ₹23.11 Cr ₹15.36 Cr
Depreciation & Amortisation ₹30.83 Cr ₹21.06 Cr ₹17.02 Cr
Other Expenses ₹219.81 Cr ₹183.36 Cr ₹161.27 Cr
Total Expenses ₹860.12 Cr ₹729.29 Cr ₹693.17 Cr
Profit Before Exceptional Items & Tax ₹86.55 Cr ₹94.14 Cr ₹115.67 Cr
Exceptional Items ₹0 ₹0 ₹0
Profit Before Tax ₹86.55 Cr ₹94.14 Cr ₹115.67 Cr
Total Tax Expense ₹22.34 Cr ₹24.49 Cr ₹29.54 Cr
Net Profit ₹64.21 Cr ₹69.65 Cr ₹86.14 Cr
  attributable to Owners ₹0 ₹0 -
  attributable to NCI -₹20,000 -₹8,000 -
Other Comprehensive Income ₹49.93 Lakh -₹12.77 Lakh -₹40.39 Lakh
Total Comprehensive Income ₹64.71 Cr ₹69.52 Cr ₹85.73 Cr
EBITDA (computed) ₹153.99 Cr ₹138.32 Cr ₹148.05 Cr
Basic EPS ₹6.40 ₹6.95 ₹8.74
Diluted EPS ₹6.40 ₹6.95 ₹8.74
Metrics FY 2026 FY 2025 FY 2024
Total Assets ₹1,342.37 Cr ₹1,169.36 Cr ₹1,092.54 Cr
Non-current Assets ₹540.26 Cr ₹544.84 Cr ₹492.06 Cr
Current Assets ₹802.12 Cr ₹624.52 Cr ₹600.48 Cr
Property, Plant & Equipment ₹484.85 Cr ₹499.65 Cr ₹153.27 Cr
Inventories ₹324.47 Cr ₹216.87 Cr ₹200.48 Cr
Trade Receivables ₹297.4 Cr ₹314.61 Cr ₹329.94 Cr
Cash & Equivalents ₹62.19 Cr ₹15.72 Cr ₹1.14 Cr
Equity (Net Worth) ₹664.99 Cr ₹601.08 Cr ₹532.56 Cr
Equity Share Capital ₹10.03 Cr ₹10.03 Cr ₹10.03 Cr
Borrowings (Non-current) ₹105.04 Cr ₹130.5 Cr ₹153.96 Cr
Borrowings (Current) ₹280.13 Cr ₹179.88 Cr ₹163.07 Cr
Total Debt (computed) ₹385.16 Cr ₹310.37 Cr ₹317.03 Cr
Current Liabilities ₹517.85 Cr ₹387.56 Cr ₹372.05 Cr
Total Liabilities ₹677.39 Cr ₹568.29 Cr ₹559.98 Cr
Metrics FY 2026 FY 2025 FY 2024
Operating Cash Flow ₹44.97 Cr ₹122.57 Cr -₹7.46 Cr
Investing Cash Flow -₹30.96 Cr -₹70.78 Cr -₹102.39 Cr
Financing Cash Flow ₹32.46 Cr -₹37.2 Cr ₹82.38 Cr
Capital Expenditure ₹31.18 Cr ₹75.53 Cr ₹112.69 Cr
Free Cash Flow (computed) ₹13.79 Cr ₹47.04 Cr -₹120.15 Cr
Dividends Paid ₹1 Cr ₹1 Cr ₹96.94 Lakh
Net Change in Cash ₹46.46 Cr ₹14.59 Cr -₹27.47 Cr
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24
Revenue from Operations ₹251.82 Cr ₹231.41 Cr ₹237.05 Cr ₹223.72 Cr ₹205.02 Cr ₹207.79 Cr ₹204.18 Cr ₹202.81 Cr ₹194.99 Cr ₹201.78 Cr ₹214.87 Cr
Other Income -₹1.17 Cr ₹79.05 Lakh ₹2.12 Cr ₹92.52 Lakh ₹39.45 Lakh ₹1.86 Cr ₹11.38 Lakh ₹1.25 Cr ₹88.14 Lakh ₹42.36 Lakh ₹33.44 Lakh
Total Income ₹250.65 Cr ₹232.2 Cr ₹239.17 Cr ₹224.65 Cr ₹205.41 Cr ₹209.66 Cr ₹204.29 Cr ₹204.07 Cr ₹195.87 Cr ₹202.2 Cr ₹215.21 Cr
Cost of Materials Consumed ₹124.07 Cr ₹99.27 Cr ₹113.47 Cr ₹88.52 Cr ₹122.91 Cr ₹73.59 Cr ₹74.93 Cr ₹72.77 Cr ₹90.95 Cr ₹72.92 Cr ₹95.29 Cr
Purchases of Stock-in-Trade ₹8.93 Cr ₹15.82 Cr ₹25.69 Cr ₹14.27 Cr ₹10.85 Cr ₹15.55 Cr ₹16.57 Cr ₹12.45 Cr ₹14.34 Cr ₹12 Cr ₹15.66 Cr
Changes in Inventories -₹18.06 Cr -₹14.07 Cr -₹34.72 Cr -₹2.01 Cr -₹44.09 Cr ₹5.03 Cr ₹4.62 Cr ₹9.53 Cr -₹16.68 Cr ₹10.41 Cr -₹1.84 Cr
Employee Benefit Expense ₹38.14 Cr ₹40.09 Cr ₹37.45 Cr ₹36 Cr ₹35.57 Cr ₹33.96 Cr ₹28.47 Cr ₹29.05 Cr ₹29.6 Cr ₹30.6 Cr ₹26.78 Cr
Finance Costs ₹9.44 Cr ₹8.36 Cr ₹9.58 Cr ₹9.23 Cr ₹8.4 Cr ₹4.91 Cr ₹5.18 Cr ₹4.62 Cr ₹3.65 Cr ₹3.18 Cr ₹4.46 Cr
Depreciation & Amortisation ₹7.65 Cr ₹7.69 Cr ₹7.77 Cr ₹7.72 Cr ₹7.84 Cr ₹4.62 Cr ₹4.3 Cr ₹4.31 Cr ₹4.34 Cr ₹4.14 Cr ₹4.3 Cr
Other Expenses ₹51.52 Cr ₹57.32 Cr ₹57.32 Cr ₹53.65 Cr ₹53.4 Cr ₹45.75 Cr ₹40.96 Cr ₹43.25 Cr ₹42.55 Cr ₹39.38 Cr ₹39.62 Cr
Total Expenses ₹221.7 Cr ₹214.48 Cr ₹216.57 Cr ₹207.37 Cr ₹194.89 Cr ₹183.4 Cr ₹175.04 Cr ₹175.96 Cr ₹168.76 Cr ₹172.64 Cr ₹184.26 Cr
Profit Before Exceptional Items & Tax ₹28.95 Cr ₹17.72 Cr ₹22.6 Cr ₹17.27 Cr ₹10.52 Cr ₹26.26 Cr ₹29.25 Cr ₹28.1 Cr ₹27.12 Cr ₹29.56 Cr ₹30.95 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹28.95 Cr ₹17.72 Cr ₹22.6 Cr ₹17.27 Cr ₹10.52 Cr ₹26.26 Cr ₹29.25 Cr ₹28.1 Cr ₹27.12 Cr ₹29.56 Cr ₹30.95 Cr
Total Tax Expense ₹7.05 Cr ₹5.3 Cr ₹5.78 Cr ₹4.2 Cr ₹2.81 Cr ₹6.96 Cr ₹7.49 Cr ₹7.25 Cr ₹7.07 Cr ₹7.3 Cr ₹7.74 Cr
Net Profit ₹21.9 Cr ₹12.42 Cr ₹16.82 Cr ₹13.07 Cr ₹7.72 Cr ₹19.31 Cr ₹21.77 Cr ₹20.86 Cr ₹20.05 Cr ₹22.26 Cr ₹23.21 Cr
  attributable to Owners ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 - - -
  attributable to NCI ₹0 ₹0 -₹14,000 ₹0 ₹0 -₹1,000 -₹6,000 -₹1,000 - - -
Other Comprehensive Income ₹49.93 Lakh ₹0 ₹0 ₹0 -₹12.77 Lakh ₹0 ₹0 ₹0 -₹40.39 Lakh ₹0 ₹0
Total Comprehensive Income ₹22.4 Cr ₹12.42 Cr ₹16.82 Cr ₹13.07 Cr ₹7.59 Cr ₹19.31 Cr ₹21.77 Cr ₹20.86 Cr ₹19.64 Cr ₹22.26 Cr ₹23.21 Cr
EBITDA (computed) ₹46.04 Cr ₹33.77 Cr ₹39.96 Cr ₹34.23 Cr ₹26.77 Cr ₹35.79 Cr ₹38.73 Cr ₹37.03 Cr ₹35.11 Cr ₹36.88 Cr ₹39.7 Cr
Basic EPS ₹2.18 ₹1.24 ₹1.68 ₹1.30 ₹0.77 ₹1.93 ₹2.17 ₹2.08 ₹2.00 ₹2.23 ₹2.39
Diluted EPS ₹2.18 ₹1.24 ₹1.68 ₹1.30 ₹0.77 ₹1.93 ₹2.17 ₹2.08 ₹2.00 ₹2.23 ₹2.39
Latest 11 quarters shown.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹940.48 Cr ₹819.81 Cr ₹806.67 Cr ₹690.62 Cr ₹779.16 Cr ₹487.7 Cr ₹357.75 Cr
Other Income ₹2.58 Cr ₹3.62 Cr ₹2.18 Cr ₹2.57 Cr ₹3.1 Cr ₹3.73 Cr ₹6.82 Cr
Total Income ₹943.06 Cr ₹823.42 Cr ₹808.84 Cr ₹693.19 Cr ₹782.26 Cr ₹491.43 Cr ₹364.57 Cr
Cost of Materials Consumed ₹425.33 Cr ₹344.2 Cr ₹341.32 Cr ₹339.36 Cr ₹353.93 Cr ₹213.45 Cr ₹152.98 Cr
Purchases of Stock-in-Trade ₹64.73 Cr ₹55.41 Cr ₹58.06 Cr ₹25.84 Cr ₹77.42 Cr ₹22.55 Cr ₹37.22 Cr
Changes in Inventories -₹68.86 Cr -₹24.91 Cr -₹9.49 Cr -₹33.39 Cr -₹19.39 Cr ₹14.29 Cr -₹12.73 Cr
Employee Benefit Expense ₹151.68 Cr ₹127.05 Cr ₹109.63 Cr ₹86.73 Cr ₹85.61 Cr ₹66.22 Cr ₹51.57 Cr
Finance Costs ₹36.61 Cr ₹23.11 Cr ₹15.36 Cr ₹8.22 Cr ₹4.85 Cr ₹13.63 Cr ₹12.72 Cr
Depreciation & Amortisation ₹30.83 Cr ₹21.06 Cr ₹17.02 Cr ₹22.28 Cr ₹17.13 Cr ₹16.31 Cr ₹8.35 Cr
Other Expenses ₹217.25 Cr ₹183.07 Cr ₹161.27 Cr ₹137.42 Cr ₹135.87 Cr ₹87.27 Cr ₹84.12 Cr
Total Expenses ₹857.57 Cr ₹728.99 Cr ₹693.17 Cr ₹586.47 Cr ₹655.42 Cr ₹433.72 Cr ₹334.24 Cr
Profit Before Exceptional Items & Tax ₹85.49 Cr ₹94.43 Cr ₹115.67 Cr ₹106.72 Cr ₹126.84 Cr ₹57.71 Cr ₹30.33 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹85.49 Cr ₹94.43 Cr ₹115.67 Cr ₹106.72 Cr ₹126.84 Cr ₹57.71 Cr ₹30.33 Cr
Total Tax Expense ₹22.34 Cr ₹24.49 Cr ₹29.54 Cr ₹27.02 Cr ₹31 Cr ₹13.48 Cr ₹7.47 Cr
Net Profit ₹63.15 Cr ₹69.93 Cr ₹86.14 Cr ₹79.7 Cr ₹95.84 Cr ₹44.23 Cr ₹22.86 Cr
Other Comprehensive Income ₹49.93 Lakh -₹12.77 Lakh -₹40.39 Lakh -₹53,000 -₹44.06 Lakh ₹27.1 Lakh -₹1.98 Cr
Total Comprehensive Income ₹63.65 Cr ₹69.81 Cr ₹85.73 Cr ₹79.7 Cr ₹95.4 Cr ₹44.5 Cr ₹20.88 Cr
EBITDA (computed) ₹152.93 Cr ₹138.6 Cr ₹148.05 Cr ₹137.23 Cr ₹148.82 Cr ₹87.65 Cr ₹51.4 Cr
Basic EPS ₹6.30 ₹6.97 ₹8.74 ₹8.22 ₹9.89 ₹4.56 ₹2.94
Diluted EPS ₹6.30 ₹6.97 ₹8.74 ₹8.22 ₹9.89 ₹4.56 ₹2.94
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹1,341.59 Cr ₹1,169.63 Cr ₹1,092.54 Cr ₹861.16 Cr
Non-current Assets ₹541.33 Cr ₹545.85 Cr ₹492.07 Cr ₹397.05 Cr
Current Assets ₹800.26 Cr ₹623.78 Cr ₹600.47 Cr ₹464.11 Cr
Property, Plant & Equipment ₹484.85 Cr ₹499.65 Cr ₹153.27 Cr ₹158.89 Cr
Inventories ₹324.47 Cr ₹216.87 Cr ₹200.48 Cr ₹183.46 Cr
Trade Receivables ₹297.4 Cr ₹314.61 Cr ₹329.94 Cr ₹205.47 Cr
Cash & Equivalents ₹60.32 Cr ₹14.91 Cr ₹1.13 Cr ₹28.6 Cr
Equity (Net Worth) ₹664.18 Cr ₹601.36 Cr ₹532.56 Cr ₹347.81 Cr
Equity Share Capital ₹10.03 Cr ₹10.03 Cr ₹10.03 Cr ₹9.69 Cr
Borrowings (Non-current) ₹105.04 Cr ₹130.5 Cr ₹153.96 Cr ₹190.68 Cr
Borrowings (Current) ₹280.13 Cr ₹179.88 Cr ₹163.07 Cr ₹120.73 Cr
Total Debt (computed) ₹385.16 Cr ₹310.37 Cr ₹317.03 Cr ₹311.41 Cr
Current Liabilities ₹517.87 Cr ₹387.53 Cr ₹372.05 Cr ₹288.21 Cr
Total Liabilities ₹677.41 Cr ₹568.26 Cr ₹559.98 Cr ₹513.35 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹44.02 Cr ₹122.78 Cr -₹7.46 Cr -₹26.59 Cr ₹104.44 Cr
Investing Cash Flow -₹30.96 Cr -₹71.79 Cr -₹102.4 Cr -₹190.73 Cr -₹95.94 Cr
Financing Cash Flow ₹32.36 Cr -₹37.2 Cr ₹82.38 Cr ₹234.31 Cr -₹3.1 Cr
Capital Expenditure ₹31.18 Cr ₹75.52 Cr ₹112.69 Cr ₹187.6 Cr ₹88.8 Cr
Free Cash Flow (computed) ₹12.84 Cr ₹47.25 Cr -₹120.15 Cr -₹214.19 Cr ₹15.64 Cr
Dividends Paid ₹1 Cr ₹1 Cr ₹96.94 Lakh ₹1.04 Cr ₹92.11 Lakh
Net Change in Cash ₹45.42 Cr ₹13.78 Cr -₹27.48 Cr ₹16.99 Cr ₹5.41 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹252.05 Cr ₹231.09 Cr ₹230.42 Cr ₹226.91 Cr ₹205.02 Cr ₹207.79 Cr ₹204.18 Cr ₹202.81 Cr ₹194.99 Cr ₹201.78 Cr ₹214.87 Cr ₹195.02 Cr
Other Income -₹1.2 Cr ₹79.32 Lakh ₹2.09 Cr ₹89.42 Lakh ₹38.3 Lakh ₹1.86 Cr ₹11.38 Lakh ₹1.25 Cr ₹88.14 Lakh ₹42.36 Lakh ₹33.44 Lakh ₹88.12 Lakh
Total Income ₹250.86 Cr ₹231.89 Cr ₹232.51 Cr ₹227.81 Cr ₹205.4 Cr ₹209.66 Cr ₹204.29 Cr ₹204.07 Cr ₹195.87 Cr ₹202.2 Cr ₹215.21 Cr ₹195.9 Cr
Cost of Materials Consumed ₹124.27 Cr ₹99.07 Cr ₹113.47 Cr ₹88.52 Cr ₹122.91 Cr ₹73.59 Cr ₹74.93 Cr ₹72.77 Cr ₹90.95 Cr ₹72.92 Cr ₹95.29 Cr ₹80.38 Cr
Purchases of Stock-in-Trade ₹8.95 Cr ₹15.82 Cr ₹25.69 Cr ₹14.27 Cr ₹10.85 Cr ₹15.55 Cr ₹16.57 Cr ₹12.45 Cr ₹14.34 Cr ₹12 Cr ₹15.66 Cr ₹16.06 Cr
Changes in Inventories -₹18.06 Cr -₹14.07 Cr -₹39.25 Cr ₹2.52 Cr -₹44.09 Cr ₹5.03 Cr ₹4.62 Cr ₹9.53 Cr -₹16.68 Cr ₹10.41 Cr -₹1.84 Cr ₹39.44 Lakh
Employee Benefit Expense ₹38.14 Cr ₹40.09 Cr ₹37.45 Cr ₹36 Cr ₹35.57 Cr ₹33.96 Cr ₹28.47 Cr ₹29.05 Cr ₹29.6 Cr ₹30.6 Cr ₹26.78 Cr ₹23.37 Cr
Finance Costs ₹9.44 Cr ₹8.36 Cr ₹9.58 Cr ₹9.23 Cr ₹8.4 Cr ₹4.91 Cr ₹5.18 Cr ₹4.62 Cr ₹3.65 Cr ₹3.18 Cr ₹4.46 Cr ₹4.07 Cr
Depreciation & Amortisation ₹7.65 Cr ₹7.69 Cr ₹7.77 Cr ₹7.72 Cr ₹7.84 Cr ₹4.62 Cr ₹4.3 Cr ₹4.31 Cr ₹4.34 Cr ₹4.14 Cr ₹4.3 Cr ₹4.24 Cr
Other Expenses ₹52.83 Cr ₹53.88 Cr ₹57.27 Cr ₹53.27 Cr ₹53.14 Cr ₹45.73 Cr ₹40.95 Cr ₹43.24 Cr ₹42.55 Cr ₹39.38 Cr ₹39.62 Cr ₹39.33 Cr
Total Expenses ₹223.23 Cr ₹210.84 Cr ₹211.98 Cr ₹211.53 Cr ₹194.62 Cr ₹183.38 Cr ₹175.03 Cr ₹175.96 Cr ₹168.76 Cr ₹172.64 Cr ₹184.26 Cr ₹167.85 Cr
Profit Before Exceptional Items & Tax ₹27.63 Cr ₹21.05 Cr ₹20.53 Cr ₹16.28 Cr ₹10.78 Cr ₹26.28 Cr ₹29.26 Cr ₹28.11 Cr ₹27.12 Cr ₹29.56 Cr ₹30.95 Cr ₹28.05 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹27.63 Cr ₹21.05 Cr ₹20.53 Cr ₹16.28 Cr ₹10.78 Cr ₹26.28 Cr ₹29.26 Cr ₹28.11 Cr ₹27.12 Cr ₹29.56 Cr ₹30.95 Cr ₹28.05 Cr
Total Tax Expense ₹7.05 Cr ₹5.49 Cr ₹5.59 Cr ₹4.2 Cr ₹2.81 Cr ₹6.96 Cr ₹7.49 Cr ₹7.25 Cr ₹7.07 Cr ₹7.3 Cr ₹7.74 Cr ₹7.43 Cr
Net Profit ₹20.57 Cr ₹15.56 Cr ₹14.94 Cr ₹12.07 Cr ₹7.97 Cr ₹19.32 Cr ₹21.78 Cr ₹20.86 Cr ₹20.05 Cr ₹22.26 Cr ₹23.21 Cr ₹20.62 Cr
Other Comprehensive Income ₹49.93 Lakh ₹0 ₹0 ₹0 -₹12.77 Lakh ₹0 ₹0 ₹0 -₹40.39 Lakh ₹0 ₹0 ₹0
Total Comprehensive Income ₹21.07 Cr ₹15.56 Cr ₹14.94 Cr ₹12.07 Cr ₹7.85 Cr ₹19.32 Cr ₹21.78 Cr ₹20.86 Cr ₹19.64 Cr ₹22.26 Cr ₹23.21 Cr ₹20.62 Cr
EBITDA (computed) ₹44.71 Cr ₹37.1 Cr ₹37.89 Cr ₹33.23 Cr ₹27.02 Cr ₹35.81 Cr ₹38.74 Cr ₹37.04 Cr ₹35.11 Cr ₹36.88 Cr ₹39.7 Cr ₹36.36 Cr
Basic EPS ₹2.05 ₹1.55 ₹1.49 ₹1.20 ₹0.80 ₹1.93 ₹2.17 ₹2.08 ₹2.00 ₹2.23 ₹2.39 ₹2.13
Diluted EPS ₹2.05 ₹1.55 ₹1.49 ₹1.20 ₹0.80 ₹1.93 ₹2.17 ₹2.08 ₹2.00 ₹2.23 ₹2.39 ₹2.13
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Gufic Biosciences Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Gufic Biosciences Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 72.50%, foreign institutional investors hold 0.42%, domestic institutional investors hold 3.83%, retail and other public shareholders hold 23.24% of Gufic Biosciences Limited. The company had 29,223 shareholders on record.

Promoters: 72.50%DII (Domestic Institutional): 3.83%FII (Foreign Institutional): 0.42%Retail & Others: 23.24%
Mar 2026
QUARTER
72.50% Promoters
3.83% DII (Domestic Institutional)
0.42% FII (Foreign Institutional)
23.24% Retail & Others
Promoter holding - history
Now 72.50% · Mar 2026High 75.48% · Jun 2021Low 65.73% · Dec 2017
64%67.3%70.5%73.8%77%Dec 2015Jun 2018Dec 2020Jun 2023Sep 2025Dec 2015: 69.98%Mar 2016: 69.98%Jun 2016: 69.98%Sep 2016: 69.98%Dec 2016: 69.98%Mar 2017: 69.98%Jun 2017: 69.98%Sep 2017: 69.98%Dec 2017: 65.73%Mar 2018: 65.73%Jun 2018: 65.73%Sep 2018: 65.75%Dec 2018: 65.75%Mar 2019: 65.75%Jun 2019: 65.75%Sep 2019: 65.75%Dec 2019: 65.75%Mar 2020: 65.75%Jun 2020: 65.75%Sep 2020: 65.75%Dec 2020: 65.75%Mar 2021: 65.75%Jun 2021: 75.48%Sep 2021: 75.48%Dec 2021: 75.48%Mar 2022: 75.48%Jun 2022: 75.00%Sep 2022: 75.00%Dec 2022: 75.00%Mar 2023: 75.00%Jun 2023: 75.00%Sep 2023: 75.00%Oct 2023: 72.51%Dec 2023: 72.51%Mar 2024: 72.51%Jun 2024: 72.51%Sep 2024: 72.51%Dec 2024: 72.51%Mar 2025: 72.51%Jun 2025: 72.51%Sep 2025: 72.50%Dec 2025: 72.50%Mar 2026: 72.50%75.48%65.73%72.50%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters72.50%72.50%72.50%72.51%72.51%72.51%
Public27.50%27.50%27.50%27.49%27.49%27.49%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters72.50%72.51%72.51%75.00%75.48%65.75%65.75%65.75%65.73%69.98%69.98%
Public27.50%27.49%27.49%25.00%24.52%34.25%34.25%34.25%34.27%30.02%30.02%
Promoter change (YoY, %pts)-0.01+0.00-2.49-0.48+9.73+0.00+0.00+0.02-4.25+0.00-

Board & Governance of Gufic Biosciences Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Gufic Biosciences Limited has 6 directors - 3 independent and 3 executive. The board is chaired by JAYESH PANNALAL CHOKSI.

DirectorPositionOn board sinceListed boards
JAYESH PANNALAL CHOKSI Executive Director · MD · Chairperson 2009-08-31 1
PRANAV JAYESH CHOKSI Executive Director · CEO 2004-06-25 1
PANKAJ JAYAKUMAR GANDHI Executive Director 2013-08-01 1
ANU SANJIV AURORA Non-Executive - Independent Director 2019-12-23 1
KAMAL KISHORE SETH Non-Executive - Independent Director 2024-06-27 2
AKSHYA KUMAR MAHAPATRA Non-Executive - Independent Director 2024-11-14 1
Board Committees
CommitteeMembers
Audit Committee KAMAL KISHORE SETH (Chairperson), ANU SANJIV AURORA, JAYESH PANNALAL CHOKSI, AKSHYA KUMAR MAHAPATRA
Nomination and remuneration committee ANU SANJIV AURORA (Chairperson), KAMAL KISHORE SETH, AKSHYA KUMAR MAHAPATRA
Stakeholders Relationship Committee ANU SANJIV AURORA (Chairperson), JAYESH PANNALAL CHOKSI, PRANAV JAYESH CHOKSI
Risk Management Committee JAYESH PANNALAL CHOKSI (Chairperson), PRANAV JAYESH CHOKSI, ANU SANJIV AURORA, NAGESH YARRABATHINA, DEVKINANDAN B. ROONGHTA
Corporate Social Responsibility Committee JAYESH PANNALAL CHOKSI (Chairperson), PRANAV JAYESH CHOKSI, ANU SANJIV AURORA

Group Structure of Gufic Biosciences Limited

Gufic Biosciences Limited has 1 subsidiary company. This group structure data is as of FY 2025. The corporate group structure reflects Gufic Biosciences Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Gufic Prime Private Limited U46497MP2023PTC068618 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Gufic Biosciences Limited

Open charges
₹604.73 Cr
Satisfied charges
₹201.91 Cr
Breakdown by lending institutions
Others₹347.96 Cr
Hdfc Bank Limited₹205.00 Cr
Axis Bank Limited₹50.77 Cr
The Saraswat Co-Op Bank Ltd₹0.80 Cr
The Memon Co-Op.; Bank Ltd.₹0.20 Cr
Latest charge details
DateLenderAmountStatus
26 Sep 2025 Others ₹15.3 Lakh Open
31 Jan 2025 Others ₹29.5 Lakh Open
31 Jan 2025 Others ₹29.5 Lakh Open
18 Jun 2024 Others ₹80 Cr Open
31 May 2024 Others ₹10 Lakh Open

Total charge records: 54 View all charges

Employees and EPFO Compliance at Gufic Biosciences Limited

Gufic Biosciences Limited has a workforce of 1,362 employees as of Sep 23, 2025.

Employee count
1,362
Active EPFO establishments
2
Employee growth
-11.04%
Premium access

Employee and EPFO history for Gufic Biosciences Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Gufic Biosciences Limited

Premium access

GST registrations and filing compliance for Gufic Biosciences Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Gufic Biosciences Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Gufic Biosciences Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Gufic Biosciences Limited

Premium access

MSME payment history for Gufic Biosciences Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Gufic Biosciences Limited

Premium access

Corporate group structure for Gufic Biosciences Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Gufic Biosciences Limited

Premium access

MCA filings and documents for Gufic Biosciences Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Gufic Biosciences Limited

Charges
24 Jun 2026
A charge registered on 14 Feb 2022 via Charge ID 100545057 with Others was fully satisfied on 24 Jun 2026.
Activity
29 Sep 2025
Gufic Biosciences Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
26 Sep 2025
A charge with Others amounted to Rs. 0.15 Cr with Charge ID 101170931 was registered on 26 Sep 2025.
Charges
22 Sep 2025
A charge with Others of Rs. 80.00 Cr registered on 18 Jun 2024 with Charge ID 100943872 was modified on 22 Sep 2025.
Charges
19 Sep 2025
A charge with Hdfc Bank Limited of Rs. 205.00 Cr registered on 08 Dec 2022 with Charge ID 100670629 was modified on 19 Sep 2025.
Charges
31 May 2025
A charge with Others of Rs. 33.00 Cr registered on 04 Jan 2013 with Charge ID 10397211 was modified on 31 May 2025.

Recent News on Gufic Biosciences Limited

Frequently Asked Questions about Gufic Biosciences Limited

Gufic Biosciences Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 23 July 1984 (42+ years old) and is registered under CIN L24100MH1984PLC033519. Listed on BSE: 509079 and NSE: GUFICBIO. The company has 1,362 employees.

Gufic Biosciences Limited reported revenue of ₹944.01 Cr for FY 2026 (up 15.15% YoY) based on consolidated NSE filings.

The current directors of Gufic Biosciences Limited are:

The primary industry of Gufic Biosciences Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Gufic Biosciences Limited is listed on both BSE (code: 509079) and NSE (symbol: GUFICBIO).

Gufic Biosciences Limited can be reached at the registered office: Shop – 37 First Floor Kamala Bhavan Ii S Nityanand Road Andheri East, Mumbai, Maharashtra, India – 400069, or through the website gufic.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available